This paper was published in the Annales de Dermatologie et de Venereologie 2003 Feb;130(2 Pt 1):187-90
Study title and authors:
Simvastatin-induced lichen planus pemphigoides
Study title and authors:
Simvastatin-induced lichen planus pemphigoides
Stoebner PE, Michot C, Ligeron C, Durand L, Meynadier J, Meunier L.
Service de Dermatologie-Allergologie-Photobiologie, Hôpital Saint-Eloi, 80, avenue Augustin Fliche, 34295 Montpellier Cedex 5. p-stoebner@chu-montpellier.fr
This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/12671581
Service de Dermatologie-Allergologie-Photobiologie, Hôpital Saint-Eloi, 80, avenue Augustin Fliche, 34295 Montpellier Cedex 5. p-stoebner@chu-montpellier.fr
This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/12671581
Lichen planus pemphigoides is a rare autoimmune blistering disease that is characterized by the development of erupting fluid from skin lesions.
Stoebner describes the case of a 63-year-old man who developed lichen planus pemphigoides lesions after two months treatment with simvastatin. All the lesions progressively disappeared after simvastatin treatment was discontinued.
With the increasing use of statins Stoebbner concludes: "An association between simvastatin and lichen planus pemphigoides should be kept in mind".
